Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target

Cited by (394)

Items 101–200 of 394

1. Age‐dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging
   Liang Sun, Zhiming Li, Caiyou Hu, Jiahong Ding, Qi Zhou, Guofang Pang, Zhu Wu, Ruiyue Yang, Shenghui Li, Jian Li et al. · 2023 · Aging Cell
2. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease
   Chih‐Yu Yang, Ting-Wen Chen, Wan-Lun Lu, Shih‐Shin Liang, Hsien‐Da Huang, Ching‐Ping Tseng, Der‐Cherng Tarng · 2021 · Cells
3. Organ Crosstalk in Acute Kidney Injury: Evidence and Mechanisms
   Xiaolong Li, Feifei Yuan, Lili Zhou · 2022 · Journal of Clinical Medicine
4. Exploring the Preventive and Therapeutic Mechanisms of Probiotics in Chronic Kidney Disease through the Gut–Kidney Axis
   Hsiao-Wen Huang, Ming‐Ju Chen · 2024 · Journal of Agricultural and Food Chemistry
5. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease
   Daniel Yuhang Li, W.H. Wilson Tang · 2018 · Seminars in Nephrology
6. Effects of Microbiota-Driven Therapy on Circulating Indoxyl Sulfate and P-Cresyl Sulfate in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
   Li Chen, Junhe Shi, Xiaojuan Ma, Dazhuo Shi, Hua Qu · 2021 · Advances in Nutrition
7. Distant organ dysfunction in acute kidney injury
   Faeq Husain‐Syed, Mitchell Howard Rosner, Claudio Ronco · 2019 · Acta Physiologica
8. Role of Gut Microbiota in Combating Oxidative Stress
   Bomba Dam, Arijit Misra, Sohini Banerjee · 2019 · Springer eBooks
9. Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota
   Yinhua Ni, Liujie Zheng, Sujie Nan, Lehui Ke, Zhengwei Fu, Juan Jin · 2022 · Acta Biochimica et Biophysica Sinica
10. Simultaneous quantitative analysis of uremic toxins by LC–MS/MS with a reversed-phase/cation-exchange/anion-exchange tri-modal mixed-mode column
    Yoshitomi Kanemitsu, Kei Asaji, Yotaro Matsumoto, Hiroki Tsukamoto, Daisuke Saigusa, Chikahisa Mukawa, Tatsuki Tachikawa, Takaaki Abe, Yoshihisa Tomioka · 2017 · Journal of Chromatography B
11. Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract
    Annabel Biruete, Kathleen M. Hill Gallant, Stephen R. Lindemann, Gretchen N. Wiese, Neal X. Chen, Sharon M. Moe · 2019 · Journal of Renal Nutrition
12. Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease
    Alexander J. Prokopienko, Thomas D. Nolin · 2017 · Expert Review of Clinical Pharmacology
13. Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients
    Adil Jadoon, Anna Vachaparampil Mathew, Jaeman Byun, Crystal Ann Gadegbeku, Debbie S. Gipson, Farsad Afshinnia, Subramaniam Pennathur, for the Michigan Kidney Translational Core CPROBE Investigator Group · 2018 · American Journal of Nephrology
14. Dietary Fiber Intake, Myocardial Injury, and Major Adverse Cardiovascular Events Among End-Stage Kidney Disease Patients: A Prospective Cohort Study
    Angela Yee-Moon Wang, Mandy Man-Mei Sea, Kenway Ng, Mei Wang, Iris Hiu-Shuen Chan, Christopher Wai-Kei Lam, John Elsby Sanderson, Jean Woo · 2019 · Kidney International Reports
15. Muscle mass assessment in renal disease: the role of imaging techniques
    Alice Sabatino, Claudia D’Alessandro, Giuseppe Regolisti, Francesca Di Mario, Giuseppe Guglielmi, Alberto Bazzocchi, Enrico Fiaccadori · 2020 · Quantitative Imaging in Medicine and Surgery
16. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury
    Laurens Veldeman, Jill Vanmassenhove, Wim Van Biesen, Ziad A. Massy, Sophie Liabeuf, Griet Glorieux, Raymond Camille Vanholder · 2019 · International Urology and Nephrology
17. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease
    Johannes Benjamin Holle, Uwe Querfeld, Marietta Kirchner, Alexandros Anninos, Jürgen G. Okun, Daniela Thurn‐Valsassina, Aysun Karabay Bayazıt, Anna Niemirska, Nur Canpolat, İpek Kaplan Bulut et al. · 2019 · Pediatric Nephrology
18. Platelets in Advanced Chronic Kidney Disease: Two Sides of the Coin
    Prof. Dr. med. Jens Lutz, PD Dr. rer. nat. Kerstin Jurk · 2020 · Seminars in Thrombosis and Hemostasis
19. Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats
    Chunlan Ji, Li Yin, Yenan Mo, Zhaoyu Lu, Fuhua Lu, Qizhan Lin, Xusheng Liu, Chuan Zou, Yuchi Wu · 2021 · Frontiers in Pharmacology
20. Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
    Brandilyn A. Peters, Qibin Qi, Mykhaylo Usyk, Martha L. Daviglus, Jianwen Cai, Nora Franceschini, James Phillip Lash, Marc D. Gellman, Bing Yu, Eric Boerwinkle et al. · 2023 · Gut Microbes
21. Fermentation technology as a driver of human brain expansion
    Katherine Bryant, Christi Hansen, Erin E. Hecht · 2023 · Communications Biology
22. Intestinal metabolite TMAO promotes CKD progression by stimulating macrophage M2 polarization through histone H4 lysine 12 lactylation
    Youzhou Tang, Yuxin Li, Xinyu Yang, Tianze Lu, Xinran Wang, Zhi Li, Jun Liu, Jianwen Wang · 2025 · Cell Death and Differentiation
23. Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial
    Rachel Gatti Armani, Aluízio Barbosa Carvalho, Christiane Ishikawa Ramos, Valéria Costa‐Hong, Luiz Aparecido Bortolotto, José Luiz Cassiolato, Natacha Oliveira, Zuzana Cieslarová, Claudimir Lúcio do Lago, Aline Klassen et al. · 2020 · Nephrology Dialysis Transplantation
24. Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
    Jiaran Lin, Ziting Wang, Jiao-Jiao Sun, Yingying Yang, Xuexin Li, Xinru Wang, Yue Shi, Yuan‐Yuan Zhu, Ruiting Wang, Mina Wang et al. · 2022 · World Journal of Diabetes
25. Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: A double-blind, randomized, placebo-controlled trial
    Amanda de Faria Barros, Natália Alvarenga Borges, Lia S. Nakao, Carla Juliana Ribeiro Dolenga, Flávia Lima do Carmo, Dennis de Carvalho Ferreira, Peter Stenvinkel, Peter Bergman, Bengt Lindholm, Denise Mafra · 2018 · Journal of Functional Foods
26. Microbiome-related metabolite changes in gut tissue, cecum content and feces of rats treated with antibiotics
    Christina Behr, Saskia Sperber, Xiaoqi Jiang, Volker Strauss, Hennicke Kamp, Tilmann B. Walk, Michael J. Herold, Karsten Beekmann, Ivonne M.C.M. Rietjens, Bennard van Ravenzwaay · 2018 · Toxicology and Applied Pharmacology
27. Endocrine organs of cardiovascular diseases: Gut microbiota
    Qiujin Jia, Yingyu Xie, Chunmiao Lu, Ao Zhang, Yanmin Lu, Shichao Lv, Junping Zhang · 2019 · Journal of Cellular and Molecular Medicine
28. Fecal microbiota transplantation restores normal fecal composition and delays malignant development of mild chronic kidney disease in rats
    Xiaoxue Liu, Ming Zhang, Xifan Wang, Ping Liu, Longjiao Wang, Yixuan Li, Xiaoyu Wang, Fazheng Ren · 2022 · Frontiers in Microbiology
29. Health‐related quality of life in peritoneal dialysis patients: A narrative review
    Rute Cardoso de Aguiar, Ming Pei, Abdul Rashid Qureshi, Bengt Lindholm · 2018 · Seminars in Dialysis
30. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease
    Kensei Taguchi, Kei Fukami, Bertha C. Elias, Craig R. Brooks · 2021 · Toxins
31. Diet Quality and Protein-Bound Uraemic Toxins: Investigation of Novel Risk Factors and the Role of Microbiome in Chronic Kidney Disease
    Catherine M McFarlane, Rathika Krishnasamy, Tony Stanton, Emma Savill, Matthew Snelson, Gabor Mihala, Mark Morrison, David Wayne Johnson, Katrina Louise Campbell · 2021 · Journal of Renal Nutrition
32. The bovine TRPV3 as a pathway for the uptake of Na+, Ca2+, and NH4+
    Katharina T. Schrapers, Gerhard Sponder, Franziska Liebe, Hendrik Liebe, Friederike Stumpff · 2018 · PLoS ONE
33. Synergistic role of prebiotics and probiotics in gut microbiome health: Mechanisms and clinical applications
    Tapasya Kumari, Kshirod Kumar Bag, Amit Baran Das, Sankar Chandra Deka · 2024 · Food Bioengineering
34. Plasma metabolites associated with arterial stiffness in patients with type 2 diabetes
    Naoto Katakami, Kazuo Omori, Naohiro Taya, Shoya Arakawa, Mitsuyoshi Takahara, Taka‐aki Matsuoka, Hiroshi Tsugawa, Masahiro Furuno, Takeshi Bamba, Eiichiro Fukusaki et al. · 2020 · Cardiovascular Diabetology
35. Nutrients, Nutraceuticals, and Xenobiotics Affecting Renal Health
    Carmela Cosola, Alice Sabatino, Ighli di Bari, Enrico Fiaccadori, Loreto Gesualdo · 2018 · Nutrients
36. Gut microbiota; an overlooked effect of phosphate binders
    Yalda Rahbar Saadat, Bahram Niknafs, Seyed Mahdi Hosseiniyan Khatibi, Mohammadreza Ardalan, Hasan Sh. Majdi, Zahra Bahmanpoor, Sima Abediazar, Sepideh Zununi Vahed · 2019 · European Journal of Pharmacology
37. Association of Time-Updated Anion Gap With Risk of Kidney Failure in Advanced CKD: A Cohort Study
    Yuta Asahina, Yusuke Sakaguchi, Sachio Kajimoto, Koki Hattori, Yohei Doi, Tatsufumi Oka, Jun-Ya Kaimori, Yoshitaka Isaka · 2021 · American Journal of Kidney Diseases
38. Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases
    Michele Basilicata, Massimo Pieri, Giulia Marrone, Eleonora Nicolai, Manuela Di Lauro, Vincenza Paolino, Flaminia Tomassetti, Ilaria Vivarini, Patrizio Bollero, Sergio Bernardini et al. · 2023 · Metabolites
39. Gut microbiome-targeted therapeutics for chronic kidney disease: comparative efficacy of probiotic and microbial preparations
    Yi-Ke Li, Wenru Li, Huan Ren, Chen‐Lin Xiao, Zhen Guo, Jian‐Quan Luo · 2025 · Inflammopharmacology
40. Nanoparticle-Mediated Delivery of Emodin via Colonic Irrigation Attenuates Renal Injury in 5/6 Nephrectomized Rats
    Zhaoyu Lu, Chunlan Ji, Xuewen Luo, Yong Lan, Lijuan Han, Yang Chen, Xusheng Liu, Qinzhan Lin, Fuhua Lu, Xiuqing Wu et al. · 2021 · Frontiers in Pharmacology
41. Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease
    Alexander J. Prokopienko, Raymond E. West, Jason R. Stubbs, Thomas D. Nolin · 2019 · Journal of Pharmaceutical and Biomedical Analysis
42. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice
    Johnson, Cassandra, Prokopienko, Alexander J., West, Raymond E., Nolin, Thomas D., Stubbs, Jason R. · 2018 · Drug Metabolism and Disposition
43. Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review
    Fabiola Martín-del-Campo, Carla María Avesani, Peter Stenvinkel, Bengt Lindholm, Alfonso Martin Cueto-Manzano, Laura Cortés–Sanabria · 2023 · Journal of Nephrology
44. Effects of Dietary Fiber Supplementation on Modulating Uremic Toxins and Inflammation in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Wannasit Wathanavasin, Wisit Cheungpasitporn, Charat Thongprayoon, Tibor Fülöp · 2025 · Toxins
45. The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease
    Jue Zhu, Yutong Fu, Chinasa Valerie Olovo, Jianguo Xu, Qian Wu, Wei Wei, Ke Jiang, Xueming Zheng · 2025 · Frontiers in Microbiology
46. Renal damage in the metabolic syndrome (MetSx): Disorders implicated
    Trujillo Joyce, Yolanda I. Chirino, Natalia Martínez‐Tagüeña, José Pedraza‐Chaverrí · 2017 · European Journal of Pharmacology
47. The Effects of Gum Acacia on the Composition of the Gut Microbiome and Plasma Levels of Short-Chain Fatty Acids in a Rat Model of Chronic Kidney Disease
    Maha Al‐Asmakh, Muhammad Umar Sohail, Ola Al-Jamal, Banan Mosaad Shoair, Asmaa Yousef Al-Baniali, Salma Bouabidi, Shahd Nasr, Hiba Ahmad Bawadi · 2020 · Frontiers in Pharmacology
48. A history of uremic toxicity and of the European Uremic Toxin Work Group (EUTox)
    Raymond Camille Vanholder, Àngel Argilés, Joachim Jankowski, for the European Uremic Toxin Work Group (EUTox) · 2021 · Clinical Kidney Journal
49. Differences in the gut microbiome across typical ageing and in Parkinson's disease
    Nathan D. Nuzum, Ewa A. Szymlek‐Gay, Stella Loke, Samantha L. Dawson, Wei‐Peng Teo, Ashlee M. Hendy, Amy Loughman, Helen Macpherson · 2023 · Neuropharmacology
50. Intestinal flora alterations in patients with early chronic kidney disease: a case-control study among the Han population in southwestern China
    Qiongdan Hu, Kaiyan Wu, Wei Pan, Yan Jun Zeng, Keqin Hu, Dingguo Chen, Xinchun Huang, Qiong Zhang · 2020 · Journal of International Medical Research
51. Gut microbiota axis: potential target of phytochemicals from plant-based foods
    Ruyu Shi, Congying Huang, Yuan Gao, Xing Li, Chunhong Zhang, Minhui Li · 2023 · Food Science and Human Wellness
52. The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease
    Xiaofang Wu, Lei Zhao, Yújiāng Zhāng, Kailong Li, Jurong Yang · 2023 · Frontiers in Physiology
53. Breast milk urea as a nitrogen source for urease positiveBifidobacterium infantis
    Patrick Schimmel, Lennart Kleinjans, Roger S. Bongers, Jan Knol, Clara Belzer · 2021 · FEMS Microbiology Ecology
54. Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease
    Ebru Melekoğlu, Mehmet Alper Çetinkaya, Şerife Evrim Kepekçi Tekkeli, Oğuz Kul, Gülhan Samur · 2021 · PLoS ONE
55. The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome–metabolome combined validation in a mouse model
    Jin Shang, Wen Cui, Ruixue Guo, Yiding Zhang, Peipei Wang, Wei Yu, Xuejun Zheng, Ting Wang, Yijun Dong, Jing Zhao et al. · 2022 · Frontiers in Endocrinology
56. Comprehensive and semi-quantitative analysis of carboxyl-containing metabolites related to gut microbiota on chronic kidney disease using 2-picolylamine isotopic labeling LC-MS/MS
    Yoshitomi Kanemitsu, Eikan Mishima, Masamitsu Maekawa, Yotaro Matsumoto, Daisuke Saigusa, Hiroaki Yamaguchi, Jiro Ogura, Hiroki Tsukamoto, Yoshihisa Tomioka, Takaaki Abe et al. · 2019 · Scientific Reports
57. Exposure of the Host-Associated Microbiome to Nutrient-Rich Conditions May Lead to Dysbiosis and Disease Development—an Evolutionary Perspective
    Tim Lachnit, Thomas C. G. Bosch, Peter Deines · 2019 · mBio
58. Dialysis Procedures Alter Metabolic Conditions
    Bernd Georg Stegmayr · 2017 · Nutrients
59. Methyl Donor Nutrients in Chronic Kidney Disease: Impact on the Epigenetic Landscape
    Mafra, Denise, Esgalhado, Marta, Borges, Natalia A, Cardozo, Ludmila F M F, Stockler-Pinto, Milena B, Craven, Hannah, Buchanan, Sarah J, Lindholm, Bengt, Stenvinkel, Peter, Shiels, Paul G · 2019 · The Journal of Nutrition
60. Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion
    Matthew B. Rivara, Leila R. Zelnick, Andrew N. Hoofnagle, Rick Newitt, Russell P. Tracy, Mario Kratz, David S. Weigle, Bryan R. Kestenbaum · 2017 · Clinical Chemistry
61. Microbiota, renal disease and renal transplantation
    Maurizio Salvadori, Aris Tsalouchos · 2021 · World Journal of Transplantation
62. Gut Microbiota as a Source of Uremic Toxins
    Vasily A. Popkov, Anastasia A. Zharikova, Evgenia A. Demchenko, Nadezda V. Andrianova, Dmitry B. Zorov, Egor Y. Plotnikov · 2022 · International Journal of Molecular Sciences
63. Dietary strategies for gut-derived protein-bound uremic toxins and cardio-metabolic risk factors in chronic kidney disease: A focus on dietary fibers
    Ebru Melekoğlu, Gülhan Samur · 2021 · Critical Reviews in Food Science and Nutrition
64. The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: a randomized controlled trial
    Aida Lydia, Tities Anggraeni Indra, Aulia Rizka, Murdani Abdullah · 2022 · BMC Nephrology
65. Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC/MS-
    Kazuo Omori, Naoto Katakami, Shoya Arakawa, Yuichi Yamamoto, Hiroyo Ninomiya, Mitsuyoshi Takahara, Taka‐aki Matsuoka, Hiroshi Tsugawa, Masahiro Furuno, Takeshi Bamba et al. · 2020 · Journal of Atherosclerosis and Thrombosis
66. Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
    Mariam M. Ali, Sanober Parveen, Vanessa R. Williams, Robert F. Dons, Gabriel Ikponmosa Uwaifo · 2024 · Journal of Clinical & Translational Endocrinology
67. Laxative use in patients with advanced chronic kidney disease transitioning to dialysis
    Keiichi Sumida, Ankur A. Dashputre, Praveen Kumar Potukuchi, Fridtjof Thomas, Yoshitsugu Obi, Miklos Zsolt Molnar, Justin D. Gatwood, Elani Streja, Kamyar Kalantar‐Zadeh, Csaba Pal Kovesdy · 2020 · Nephrology Dialysis Transplantation
68. Oxalate Homeostasis in Non-Stone-Forming Chronic Kidney Disease: A Review of Key Findings and Perspectives
    Natalia Stepanova · 2023 · Biomedicines
69. Derivation and elimination of uremic toxins from kidney-gut axis
    Ying Xu, Wen-Di Bi, Yu-Xuan Shi, Xin-Rui Liang, Hai-Yan Wang, Xueli Lai, Xiaolu Bian, Zhiyong Guo · 2023 · Frontiers in Physiology
70. Therapeutic Prospective of a Spore-Forming Probiotic—Bacillus clausii UBBC07 Against Acetaminophen-Induced Uremia in Rats
    Chirag Amrutlal Patel, Priyanshi R. Patel, Sanjeev R. Acharya · 2019 · Probiotics and Antimicrobial Proteins
71. Gut microbiome-based medical methodologies for early-stage disease prevention
    Jing-Zhang Wang, Wen-Tao Du, Yanli Xu, Shu-Zhen Cheng, Zhijun Liu · 2017 · Microbial Pathogenesis
72. Insights into the gut microbiota of Nigerian elderly with type 2 diabetes and non-diabetic elderly persons
    Ayorinde O. Afolayan, Lawrence A. Adebusoye, Eniola Cadmus, Funmilola Abidemi Ayeni · 2020 · Heliyon
73. Nondestructive and multiplex differentiation of pathogenic microorganisms from spoilage microflora on seafood using paper chromogenic array and neural network
    Manyun Yang, Yaguang Luo, Arnav Sharma, Zhen Jia, Shilong Wang, Dayang Wang, Sophia Lin, Whitney Perreault, Sonia Purohit, Tingting Gu et al. · 2022 · Food Research International
74. The role of the intestinal microbiota in uremic solute accumulation: a focus on sulfur compounds
    Alessandra Fortunata Perna, Griet Glorieux, Miriam Zacchia, Francesco Trepiccione, Giovanna Capolongo, Carmela Vigorito, Evgeniya Anishchenko, Diego Ingrosso · 2019 · Journal of Nephrology
75. Marsupial Gut Microbiome
    Rowena Chong, Yuanyuan Cheng, C. Hogg, K. Belov · 2020 · Frontiers in Microbiology
76. Benefits of resistant starch type 2 for patients with end-stage renal disease under maintenance hemodialysis: a systematic review and meta-analysis
    Linpei Jia, Xingtong Dong, Xiaoxia Li, Rufu Jia, Hongliang Zhang · 2021 · International Journal of Medical Sciences
77. Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins
    Jianyong Zhong, Haichun Yang, Valery N. Yermalitsky, Elaine L. Shelton, Tadashi Otsuka, Carrie B. Wiese, Linda Zhang, Babak Banan, Naji N. Abumrad, Jiansheng Huang et al. · 2021 · Kidney International
78. Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
    Sandra Wagner, Thomas Merkling, Marie Metzger, Laetitia Koppe, Maurice Laville, Marie‐Christine Boutron‐Ruault, Luc Frimat, Christian Combe, Ziad A. Massy, Bénédicte Stengel et al. · 2022 · Frontiers in Nutrition
79. Metabolic implications of amino acid metabolites in chronic kidney disease progression: a metabolomics analysis using OPLS-DA and MBRole2.0 database
    Jianhao Kang, Xinghua Guo, Hongquan Peng, Ying Deng, Jiahui Lai, Leile Tang, Chiwa Aoieong, Tou Tou, Tsungyang Tsai, Xun Liu · 2023 · International Urology and Nephrology
80. Obesity, Weight Gain, and Fluid Overload in Peritoneal Dialysis
    Jack Kit‐Chung Ng, Win Hlaing Than, Cheuk‐Chun Szeto · 2022 · Frontiers in Nephrology
81. Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients
    Adamasco Cupisti, Piergiorgio Bolasco, Claudia D’Alessandro, Domenico Giannese, Alice Sabatino, Enrico Fiaccadori · 2021 · Toxins
82. Gut Microbiota Composition and Its Metabolites in Different Stages of Chronic Kidney Disease
    Tso-Hsiao Chen, Chao-Wei Liu, Yi-Hsien Ho, Chun-Kai Huang, Ching-Sheng Hung, Barry H. Smith, Jung-Chun Lin · 2021 · Journal of Clinical Medicine
83. Gut Microbiota as Emerging Players in the Development of Alcohol-Related Liver Disease
    Wei Li, Wenkang Gao, Qi Sheng Yan, Ling Yang, Qingjing Zhu, Huikuan Chu · 2024 · Biomedicines
84. Antibiotic-Induced Changes in Microbiome-Related Metabolites and Bile Acids in Rat Plasma
    Véronique M P de Bruijn, Christina Behr, Saskia Sperber, Tilmann B. Walk, Philipp Ternes, Markus Slopianka, Volker Haake, Karsten Beekmann, Bennard van Ravenzwaay · 2020 · Metabolites
85. Relationship between Excreted Uremic Toxins and Degree of Disorder of Children with ASD
    Joško Osredkar, Barbara Žvar Baškovič Gantar, Petra Finderle, Barbara Bobrowska‐Korczak, Paulina Gątarek, Angelina Rosiak, Joanna Giebułtowicz, Maja Jekovec Vrhovšek, Joanna Kałużna‐Czaplińska · 2023 · International Journal of Molecular Sciences
86. Enhancing Immune Protection in Hemodialysis Patients: Role of the Polymethyl Methacrylate Membrane
    Rossana Franzin, Alessandra Stasi, Gianvito Caggiano, Elena Squiccimarro, Vincenzo Losappio, Marco Fiorentino, Carlo Alfieri, Giovanni Stallone, Loreto Gesualdo, Giuseppe Castellano · 2023 · Blood Purification
87. Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin
    Ying Zhang, Shaobo Wang, Yinghui Huang, Ke Yang, Yong Liu, Xianjin Bi, Chi Liu, Jiachuan Xiong, Bo Zhang, Jinghong Zhao et al. · 2019 · Molecular Medicine Reports
88. A rapid and sensitive method for simultaneous determination of eight protein-bound uremic toxins in human serum by UHPLC-MS/MS: application in assessing peritoneal dialysis
    Zhipeng Wang, Hong Feng Jiang, Xujiao Chen, Xinhua Song, Fengjing Xu, Fangchao Chen, Zhiguo Mao, Shouhong Gao, Wansheng Chen · 2020 · Journal of Pharmaceutical and Biomedical Analysis
89. Correlation analysis of normal and moldy beef jerky microbiota with Volatile compounds
    Yexin Tian, Pu Zheng, Yingchun Mu, WEI WEN SU, Tianyan Chen · 2022 · LWT
90. Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study
    Michael B. Sohn, Bei Gao, Cynthia A. Kendrick, Anvesha Srivastava, Tamara Isakova, Jennifer Gassman, Linda F. Fried, Myles Selig Wolf, Alfred K. Cheung, Kalani L. Raphael et al. · 2023 · Kidney International Reports
91. Reduction in Serum Concentrations of Uremic Toxins Driven by Bifidobacterium Longum Subsp. Longum BL21 is Associated with Gut Microbiota Changes in a Rat Model of Chronic Kidney Disease
    Yao Dong, Zhonghui Gai, Mei Han, Jiaqi Xu, Kang Zou · 2024 · Probiotics and Antimicrobial Proteins
92. Natural polysaccharides as promising reno-protective agents for the treatment of various kidney injury
    Yufei Ye, Maoting Li, Wei Chen, Hongrui Wang, Xuhui He, Nanmei Liu, Zhiyong Guo, Chengjian Zheng · 2024 · Pharmacological Research
93. The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury
    Pauline Caillard, Youssef Bennis, Isabelle Six, Sandra Bodeau, Saı̈d Kamel, Gabriel J. Choukroun, Julien Maizel, Dimitri Titeca Beauport · 2022 · Toxins
94. Probiotics and CKD Progression: Are Creatinine-Based Estimates of GFR Applicable?
    Kenneth D. Lempert · 2019 · American Journal of Kidney Diseases
95. Percutaneous placement of femoral central venous catheter in patients undergoing transplantation of bone marrow.
    Lazarus Hm, Richard J. Creger, A D Bloom, R. Shenk · 1990 · PubMed
96. The Alteration human of gut microbiota and metabolites before and after renal transplantation
    Dong Yu, Ying Niu, Zhang Lian, Ye Qi Fa · 2021 · Microbial Pathogenesis
97. Probiotics in septic acute kidney injury, a double blind, randomized control trial
    Jonathan Samuel Chavez-Iñiguez, Miguel Ángel Ibarra-Estrada, Alejandro Martínez Gallardo-González, Ari Cisneros-Hernández, Rolando Claure‐Del Granado, Gael Chávez-Alonso, Eduardo M. Hernández-Barajas, Alexia C. Romero-Muñoz, Fidel Ramos Avellaneda, Manuel Luis Prieto-Magallanes et al. · 2023 · Renal Failure
98. Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney Disease
    Alexander J. Prokopienko, Raymond E. West, Daniel P. Schrum, Jason R. Stubbs, François A. Leblond, Vincent Pichette, Thomas D. Nolin · 2019 · Scientific Reports
99. Precision Medicine in Kidney Transplantation: Just Hype or a Realistic Hope?
    Ehsan Nobakht, Muralidharan Jagadeesan, Rohan Paul, Jonathan S. Bromberg, Sherry Dadgar · 2021 · Transplantation Direct
100. The Role of the Gut Microbiota in Complications among Hemodialysis Patients
     Junxia Du, Xiaolin Zhao, Xiaonan Ding, Qiuxia Han, Yingjie Duan, Qinqin Ren, Haoran Wang, Chenwen Song, Xiaochen Wang, Dong Zhang et al. · 2024 · Microorganisms